Product
somatropin
5 clinical trials
8 indications
Indication
Growth Hormone DisorderIndication
Adult Growth Hormone DeficiencyIndication
Genetic DisorderIndication
Noonan syndromeIndication
Growth DisorderIndication
Small for Gestational AgeIndication
Prader-Willi SyndromeIndication
Idiopathic Short StatureClinical trial
Randomized Cross Over Double Blind Versus Placebo Trial Followed by an Open Phase Studying Effect of Norditropin® on Left Ventricular Mass of Growth Hormone Deficient Adult PatientsStatus: Completed, Estimated PCD: 2002-12-01
Clinical trial
French National Longitudinal Prospective Follow-up of Children Born Small for Gestational Age and Treated With Norditropin SimpleXx (French Health Authorities Commitment)Status: Completed, Estimated PCD: 2018-10-09
Clinical trial
Genetic Testing of Noonan Subjects Previously Treated With Norditropin® in the GHNOO-1658 TrialStatus: Completed, Estimated PCD: 2008-10-01
Clinical trial
Efficacy and Safety of Norditropin® (Somatropin) in Children With Prader-Willi Syndrome (PWS)Status: Completed, Estimated PCD: 2008-11-01
Clinical trial
Efficacy and Safety of a 4 Year Combination Therapy of Growth Hormone and Gonadotropin- Releasing Hormone Agonist in Children With a Short Predicted Height.Status: Active (not recruiting), Estimated PCD: 2024-01-01